Formosa Laboratories Inc
TWSE:4746
Formosa Laboratories Inc
Accrued Liabilities
Formosa Laboratories Inc
Accrued Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accrued Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Formosa Laboratories Inc
TWSE:4746
|
Accrued Liabilities
NT$627.6m
|
CAGR 3-Years
17%
|
CAGR 5-Years
23%
|
CAGR 10-Years
11%
|
|
|
Y
|
YungShin Global Holding Corp
TWSE:3705
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ScinoPharm Taiwan Ltd
TWSE:1789
|
Accrued Liabilities
NT$143.4m
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
2%
|
|
|
S
|
SCI Pharmtech Inc
TWSE:4119
|
Accrued Liabilities
NT$99m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
1%
|
|
|
Lotus Pharmaceutical Co Ltd
TWSE:1795
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Standard Chem & Pharm Co Ltd
TWSE:1720
|
Accrued Liabilities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Formosa Laboratories Inc
Glance View
Formosa Laboratories, Inc. engages in the research and development of biotechnology new drugs. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2009-11-27. The firm primarily provides UV-proof active ingredients series products, vitamin D derivative series products, anti-inflammatory analgesic series products, steroid, anti-cancer drugs, cholesterol phosphate binding agents, nuclear magnetic resonance (NMR) reagents, respiratory disease drugs, central nervous system drugs, immune system regulators and weight loss drugs, as well as customized research and development and original equipment manufacturing (OEM) services. The firm distributes its products to Europe, the Americas, Asia and other markets.
See Also
What is Formosa Laboratories Inc's Accrued Liabilities?
Accrued Liabilities
627.6m
TWD
Based on the financial report for Dec 31, 2024, Formosa Laboratories Inc's Accrued Liabilities amounts to 627.6m TWD.
What is Formosa Laboratories Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
11%
Over the last year, the Accrued Liabilities growth was 29%. The average annual Accrued Liabilities growth rates for Formosa Laboratories Inc have been 17% over the past three years , 23% over the past five years , and 11% over the past ten years .
You don't have any saved screeners yet